首页 > 最新文献

Journal of Neurorestoratology最新文献

英文 中文
Brain iron deposition and whole-exome sequencing of non-Wilson's disease hypoceruloplasminemia in a family 一个家庭非威尔逊氏病低铜纤溶酶血症的脑铁沉积和全外显子组测序
IF 3.3 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-03-01 DOI: 10.1016/j.jnrt.2022.100027
Zhi-Xiang Xu , Yi-Yan Zhou , Rong Wu , Ya-Jie Zhao , Xiao-Ping Wang

Objective

Ceruloplasmin (CP), a key human ferroxidase, can maintain the iron balance in the brain, and the familial hypoceruloplasminemia might be rare. Ceruloplasmin reduction is one of the most common features in Wilson's disease. Some patients with hypoceruloplasminemia do not fulfill the criteria for the diagnosis of Wilson's disease or other known diseases. Moreover, these patients always suffer from various degrees of abnormal brain iron deposition. We sought to investigate the genetic basis of non-Wilson's disease hypoceruloplasminemia using whole-exome sequencing.

Methods

We recruited four patients with non-Wilson's disease hypoceruloplasminemia, who visited the Department of Neurology, Shanghai First People's Hospital, China from December 2010 to February 2011. Three of them were from the same pedigree, and the other patient shared no blood relation with the others. Iron deposition in the brain was assessed using quantitative susceptibility mapping and peripheral blood DNA was extracted. The part of the exons' genome were sequenced using the NimbleGen Sequence Capture Array and high-throughput sequencing technologies. Intersection analysis at the single nucleotide polymorphism (SNP) loci was carried out. The selected loci were verified with Sanger sequencing.

Results

Magnetic resonance imaging revealed that the magnetic susceptibility in the globus pallidus, which showed with a high signal intensity, was apparently higher in three patients than that in the normal controls, indicating the presence of abnormal iron deposition in the brain. The whole-exome sequencing and Sanger sequencing primarily excluded the possibility of mutations in the CP, ATP7B, and ATP7A genes that may impact ceruloplasmin levels. The four patients presented the homozygous mutation c.3611A>C in the C12orf51 gene; this was suspected to be a causative mutation after excluding SNP loci that were the same as those in the common population, as per The 1000 Genomes Project.

Conclusion

Non-Wilson's disease hypoceruloplasminemia showed varying degrees of abnormal iron deposition in the brain, and was possibly associated with the c.3611A>C mutation in C12orf51. How copper and iron regulate the levels of one another in the body is still not fully understood. The reduction of ceruloplasmin levels and brain iron deposition probably participated in the occurrence and development of neurodegenerative diseases. Following the combination of pre-existing techniques with a new generation of gene sequencing, the early diagnosis, prevention, and treatment of non-Wilson's disease hypoceruloplasminemia and other neurodegenerative diseases can be achieved.

目的铜蓝蛋白(CP)是一种重要的人铁氧化酶,可维持脑内铁平衡,家族性低血铁蛋白血症可能较少见。铜蓝蛋白减少是Wilson病最常见的特征之一。一些低血蛋白血症患者不符合Wilson病或其他已知疾病的诊断标准。此外,这些患者总是遭受不同程度的异常脑铁沉积。我们试图通过全外显子组测序来研究非Wilson病低血蛋白血症的遗传基础。方法我们招募了4名2010年12月至2011年2月在上海市第一人民医院神经内科就诊的非Wilson病低血蛋白血症患者。其中三名患者来自同一谱系,另一名患者与其他患者没有血缘关系。使用定量易感性图谱评估大脑中的铁沉积,并提取外周血DNA。外显子基因组的一部分使用NimbleGen序列捕获阵列和高通量测序技术进行测序。对单核苷酸多态性(SNP)位点进行了交叉分析。选择的基因座用Sanger测序进行验证。结果磁共振成像显示,三名患者的苍白球磁化率明显高于正常对照组,呈高信号强度,表明大脑中存在异常铁沉积。全外显子组测序和Sanger测序主要排除了CP、ATP7B和ATP7A基因突变可能影响铜蓝蛋白水平的可能性。这四名患者呈现纯合突变c.3611A>;C12orf51基因中的C;根据1000基因组计划,在排除与普通人群相同的SNP基因座后,这被怀疑是一种致病突变;C12orf51。铜和铁是如何调节体内的相互水平的,目前还不完全清楚。铜蓝蛋白水平的降低和脑铁沉积可能参与了神经退行性疾病的发生和发展。在将现有技术与新一代基因测序相结合后,可以实现非Wilson病低血蛋白血症和其他神经退行性疾病的早期诊断、预防和治疗。
{"title":"Brain iron deposition and whole-exome sequencing of non-Wilson's disease hypoceruloplasminemia in a family","authors":"Zhi-Xiang Xu ,&nbsp;Yi-Yan Zhou ,&nbsp;Rong Wu ,&nbsp;Ya-Jie Zhao ,&nbsp;Xiao-Ping Wang","doi":"10.1016/j.jnrt.2022.100027","DOIUrl":"https://doi.org/10.1016/j.jnrt.2022.100027","url":null,"abstract":"<div><h3>Objective</h3><p>Ceruloplasmin (CP), a key human ferroxidase, can maintain the iron balance in the brain, and the familial hypoceruloplasminemia might be rare. Ceruloplasmin reduction is one of the most common features in Wilson's disease. Some patients with hypoceruloplasminemia do not fulfill the criteria for the diagnosis of Wilson's disease or other known diseases. Moreover, these patients always suffer from various degrees of abnormal brain iron deposition. We sought to investigate the genetic basis of non-Wilson's disease hypoceruloplasminemia using whole-exome sequencing.</p></div><div><h3>Methods</h3><p>We recruited four patients with non-Wilson's disease hypoceruloplasminemia, who visited the Department of Neurology, Shanghai First People's Hospital, China from December 2010 to February 2011. Three of them were from the same pedigree, and the other patient shared no blood relation with the others. Iron deposition in the brain was assessed using quantitative susceptibility mapping and peripheral blood DNA was extracted. The part of the exons' genome were sequenced using the NimbleGen Sequence Capture Array and high-throughput sequencing technologies. Intersection analysis at the single nucleotide polymorphism (SNP) loci was carried out. The selected loci were verified with Sanger sequencing.</p></div><div><h3>Results</h3><p>Magnetic resonance imaging revealed that the magnetic susceptibility in the globus pallidus, which showed with a high signal intensity, was apparently higher in three patients than that in the normal controls, indicating the presence of abnormal iron deposition in the brain. The whole-exome sequencing and Sanger sequencing primarily excluded the possibility of mutations in the <em>CP</em>, <em>ATP7B</em>, and <em>ATP7A</em> genes that may impact ceruloplasmin levels. The four patients presented the homozygous mutation c.3611A&gt;C in the <em>C12orf51</em> gene; this was suspected to be a causative mutation after excluding SNP loci that were the same as those in the common population, as per The 1000 Genomes Project.</p></div><div><h3>Conclusion</h3><p>Non-Wilson's disease hypoceruloplasminemia showed varying degrees of abnormal iron deposition in the brain, and was possibly associated with the c.3611A&gt;C mutation in <em>C12orf51</em>. How copper and iron regulate the levels of one another in the body is still not fully understood. The reduction of ceruloplasmin levels and brain iron deposition probably participated in the occurrence and development of neurodegenerative diseases. Following the combination of pre-existing techniques with a new generation of gene sequencing, the early diagnosis, prevention, and treatment of non-Wilson's disease hypoceruloplasminemia and other neurodegenerative diseases can be achieved.</p></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"11 1","pages":"Article 100027"},"PeriodicalIF":3.3,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49888992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress in the application of motor-cognitive dual-task training in rehabilitation of walking function in stroke patients 运动认知双任务训练在脑卒中患者步行功能康复中的应用研究进展
IF 3.3 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-03-01 DOI: 10.1016/j.jnrt.2022.100028
Zhi-Quan Yang , Meng-Fan Wei , Lin Chen , Jia-Ning Xi

Restoration of walking ability in stroke patients is the basis for their return to their families and society. Motor-cognitive dual-task training (MCDTT) can effectively strengthen the functional network connection between motor and cognitive brain regions and promote brain functional network remodeling, which is more relevant to daily life than single-task training in improving walking dysfunction of stroke patients and can more effectively train patients' adaptive walking ability. This paper summarizes the application and research progress of MCDTT in post-stroke walking rehabilitation, and aims to provide a theoretical basis for further research on systematic motor-cognitive therapy techniques to promote walking rehabilitation in stroke patients.

脑卒中患者行走能力的恢复是其回归家庭和社会的基础。运动-认知双任务训练(MCDTT)能有效加强脑运动与认知区域之间的功能网络连接,促进脑功能网络重塑,在改善脑卒中患者行走功能障碍方面比单任务训练更与日常生活相关,能更有效地训练患者的适应性行走能力。本文综述了MCDTT在脑卒中后步行康复中的应用及研究进展,旨在为进一步研究系统的运动认知治疗技术促进脑卒中患者步行康复提供理论依据。
{"title":"Research progress in the application of motor-cognitive dual-task training in rehabilitation of walking function in stroke patients","authors":"Zhi-Quan Yang ,&nbsp;Meng-Fan Wei ,&nbsp;Lin Chen ,&nbsp;Jia-Ning Xi","doi":"10.1016/j.jnrt.2022.100028","DOIUrl":"10.1016/j.jnrt.2022.100028","url":null,"abstract":"<div><p>Restoration of walking ability in stroke patients is the basis for their return to their families and society. Motor-cognitive dual-task training (MCDTT) can effectively strengthen the functional network connection between motor and cognitive brain regions and promote brain functional network remodeling, which is more relevant to daily life than single-task training in improving walking dysfunction of stroke patients and can more effectively train patients' adaptive walking ability. This paper summarizes the application and research progress of MCDTT in post-stroke walking rehabilitation, and aims to provide a theoretical basis for further research on systematic motor-cognitive therapy techniques to promote walking rehabilitation in stroke patients.</p></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"11 1","pages":"Article 100028"},"PeriodicalIF":3.3,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49443717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Spinal cord stimulation improves motor function in disorders of consciousness: A case report 脊髓刺激改善意识障碍患者的运动功能一例报告
IF 3.3 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-03-01 DOI: 10.1016/j.jnrt.2023.100041
Yutong Zhuang , Guangxiao Ni , Long Xu , Xueling Chen , Xiaoli Geng , Jianghong He

A 38-year-old male patient with disorders of consciousness (DOC) successfully recovered consciousness and get obvious motor function improvements through three stages of cervical spinal cord stimulation (SCS) treatment (6 Hz, 40 Hz, and combined frequency stimulation). We used the Coma Recovery Scale-Revised (CRS-R), Fugl–Meyer Assessment Scale, activities of daily living, and Berg Balance Scale to detect changes in consciousness and motor function during the 7-month postoperative follow-up. Electroencephalography-based individual alpha frequency (IAF) and relative power spectral density (RP) were used to assess changes in cognitive function and brain network function before and after the combined stimulation. The results revealed a gradually increased patient's CRS-R score after stimulation at 6 Hz, and the patient recovered consciousness 12 weeks postoperatively. The patient's motor function score gradually increased after adjusting the stimulation frequency to 40 Hz. However, the patient regressed in motor function when the stimulation frequency was decreased to 2 Hz. The patient's fine motor control of both hands significantly improved, accompanied by an increased RP in the beta band but the IAF decreased, after combined stimulation (40 Hz and 6 Hz). Then, motor function continued to improve with an increased IAF and RP in the alpha band after switching the stimulation order to 6 Hz and 40 Hz. Our results demonstrated that different frequency stimulations of cervical SCS may improve consciousness and motor function in patients with DOC.

1例38岁男性意识障碍(DOC)患者,经6 Hz、40 Hz及联合频率刺激三期颈椎脊髓刺激(SCS)治疗后,意识恢复,运动功能明显改善。在术后7个月的随访中,我们使用昏迷恢复量表(CRS-R)、Fugl-Meyer评估量表、日常生活活动和Berg平衡量表来检测意识和运动功能的变化。采用基于脑电图的个体α频率(IAF)和相对功率谱密度(RP)评估联合刺激前后认知功能和脑网络功能的变化。结果显示,6 Hz刺激后患者的CRS-R评分逐渐升高,术后12周患者意识恢复。将刺激频率调整至40 Hz后,患者运动功能评分逐渐升高。然而,当刺激频率降至2 Hz时,患者的运动功能出现倒退。在联合刺激(40 Hz和6 Hz)后,患者的双手精细运动控制显著改善,并伴有β带RP增加,但IAF下降。然后,将刺激顺序切换到6 Hz和40 Hz后,运动功能随着α波段IAF和RP的增加而继续改善。我们的研究结果表明,不同频率的颈椎SCS刺激可以改善DOC患者的意识和运动功能。
{"title":"Spinal cord stimulation improves motor function in disorders of consciousness: A case report","authors":"Yutong Zhuang ,&nbsp;Guangxiao Ni ,&nbsp;Long Xu ,&nbsp;Xueling Chen ,&nbsp;Xiaoli Geng ,&nbsp;Jianghong He","doi":"10.1016/j.jnrt.2023.100041","DOIUrl":"10.1016/j.jnrt.2023.100041","url":null,"abstract":"<div><p>A 38-year-old male patient with disorders of consciousness (DOC) successfully recovered consciousness and get obvious motor function improvements through three stages of cervical spinal cord stimulation (SCS) treatment (6 Hz, 40 Hz, and combined frequency stimulation). We used the Coma Recovery Scale-Revised (CRS-R), Fugl–Meyer Assessment Scale, activities of daily living, and Berg Balance Scale to detect changes in consciousness and motor function during the 7-month postoperative follow-up. Electroencephalography-based individual alpha frequency (IAF) and relative power spectral density (RP) were used to assess changes in cognitive function and brain network function before and after the combined stimulation. The results revealed a gradually increased patient's CRS-R score after stimulation at 6 Hz, and the patient recovered consciousness 12 weeks postoperatively. The patient's motor function score gradually increased after adjusting the stimulation frequency to 40 Hz. However, the patient regressed in motor function when the stimulation frequency was decreased to 2 Hz. The patient's fine motor control of both hands significantly improved, accompanied by an increased RP in the beta band but the IAF decreased, after combined stimulation (40 Hz and 6 Hz). Then, motor function continued to improve with an increased IAF and RP in the alpha band after switching the stimulation order to 6 Hz and 40 Hz. Our results demonstrated that different frequency stimulations of cervical SCS may improve consciousness and motor function in patients with DOC.</p></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"11 1","pages":"Article 100041"},"PeriodicalIF":3.3,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41833300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Roles of Eph/ephrin signaling pathway in repair and regeneration for ischemic cerebrovascular and cardiovascular diseases Eph/ephrin信号通路在缺血性脑血管和心血管疾病修复和再生中的作用
IF 3.3 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-03-01 DOI: 10.1016/j.jnrt.2022.100040
Songyang Zheng , Fangling Sun , Xin Tian , Zixin Zhu , Yufeng Wang , Wenrong Zheng , Tingting Liu , Wen Wang

Ischemic cerebrovascular and cardiovascular diseases in brain and heart tissues caused by hyperlipidemia, blood viscosity, atherosclerosis, hypertension, etc. Have been increasing in morbidity and mortality in the middle-aged and elderly population over several years. In recent years, the Eph/ephrin signaling pathway has been found to have a major role in the processes of neurogenesis, synaptic plasticity, and angiogenesis, which is likely a key pathway in the modulation of neurological and cardiac functions. Therefore, an in-depth understanding of the role of the Eph/Ephrin signaling pathway in pathophysiological processes will be the emphasis of future research. In ischemic cardiovascular and cerebrovascular diseases, in particular, the development of effective treatment to modulate the Eph/Ephrin signaling pathway to promote neural and vascular repair and regeneration is of great clinical significance and social value. In this study, the role of the Eph/ephrin signaling pathway in ischemic cerebrovascular and cardiovascular diseases is reviewed.

由高脂血症、血液粘稠度、动脉粥样硬化、高血压等引起的脑和心脏组织缺血性脑血管和心血管疾病。近年来,中老年人口的发病率和死亡率一直在上升。近年来,研究发现Eph/ephrin信号通路在神经发生、突触可塑性和血管生成过程中起重要作用,可能是调节神经和心脏功能的关键途径。因此,深入了解Eph/Ephrin信号通路在病理生理过程中的作用将是今后研究的重点。特别是在缺血性心脑血管疾病中,开发有效的治疗方法,调节Eph/Ephrin信号通路,促进神经和血管的修复和再生,具有重要的临床意义和社会价值。本文就Eph/ephrin信号通路在缺血性脑血管和心血管疾病中的作用进行综述。
{"title":"Roles of Eph/ephrin signaling pathway in repair and regeneration for ischemic cerebrovascular and cardiovascular diseases","authors":"Songyang Zheng ,&nbsp;Fangling Sun ,&nbsp;Xin Tian ,&nbsp;Zixin Zhu ,&nbsp;Yufeng Wang ,&nbsp;Wenrong Zheng ,&nbsp;Tingting Liu ,&nbsp;Wen Wang","doi":"10.1016/j.jnrt.2022.100040","DOIUrl":"10.1016/j.jnrt.2022.100040","url":null,"abstract":"<div><p>Ischemic cerebrovascular and cardiovascular diseases in brain and heart tissues caused by hyperlipidemia, blood viscosity, atherosclerosis, hypertension, etc. Have been increasing in morbidity and mortality in the middle-aged and elderly population over several years. In recent years, the Eph/ephrin signaling pathway has been found to have a major role in the processes of neurogenesis, synaptic plasticity, and angiogenesis, which is likely a key pathway in the modulation of neurological and cardiac functions. Therefore, an in-depth understanding of the role of the Eph/Ephrin signaling pathway in pathophysiological processes will be the emphasis of future research. In ischemic cardiovascular and cerebrovascular diseases, in particular, the development of effective treatment to modulate the Eph/Ephrin signaling pathway to promote neural and vascular repair and regeneration is of great clinical significance and social value. In this study, the role of the Eph/ephrin signaling pathway in ischemic cerebrovascular and cardiovascular diseases is reviewed.</p></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"11 1","pages":"Article 100040"},"PeriodicalIF":3.3,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47831982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic factors of prolonged disorder of consciousness after stroke: A single centre retrospective study 中风后长期意识障碍的预后因素:一项单中心回顾性研究
IF 3.3 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-03-01 DOI: 10.1016/j.jnrt.2022.100032
Yuzhang Wu, Zhongzhen Li, Keke Feng, Yifeng Cheng, Yangang Wang, Shaoya Yin

Background

Stroke is a common disease in neurology, which often causes prolonged disorder of consciousness (pDOC) and brings a heavy burden to the patient's family and society. This study aims to explore the epidemiological factors of pDOC after stroke and the factors affecting the outcome of consciousness.

Method

The patients that admitted in Tianjin Huanhu Hospital from January 2019 to December 2021 and met the inclusion criteria were selected. Descriptive statistics was initially performed on the relevant factors of the stroke group, and statistical analysis was subsequently performed. Finally, to judge the sensitivity and specificity of the significant factors to the prediction of outcome, the receiver operating characteristic (ROC) curve of the participants was used.

Result

The statistical results showed that the location of brain injury (λ2 = 7.550, P = 0.023), cerebral hernia (λ2 = 7.534, P = 0.006), and Glasgow Coma Scale (GCS) score at onset (t = −2.479, P = 0.017) were statistically significant indicators in the improvement of consciousness in patients with pDOC after stroke. The ROC curve showed that the sensitivity and specificity of predicting the outcome of brain injury site (area under the curve [AUC] = 0.766, 95% confidence interval [CI]: 0.708–0.824) were 0.50 and 0.90, respectively, and that of cerebral hernia (AUC = 0.663, 95% CI: 0.594–0.732) were 0.73 and 0.60, respectively. The GCS score (AUC = 0.660, 95% CI: 0.596–0.724) predicted the outcome with sensitivity and specificity of 0.35 and 0.92, respectively.

Conclusion

The incidence rate of pDOC after stroke in men was higher than that in women, and the improvement rate in the consciousness level was significantly higher than that of ischemic–hypoxic encephalopathy. However, the improvement rate of the consciousness level in patients with pDOC after stroke was not related to age and gender. Cerebral hernia occurred at the time of onset, stroke occurred in the brainstem, and the low GCS score at the time of onset was significantly associated with the poor prognosis of consciousness level.

脑卒中是神经内科的常见病,常引起长期意识障碍(pDOC),给患者家庭和社会带来沉重的负担。本研究旨在探讨脑卒中后pDOC的流行病学因素及影响意识结局的因素。方法选择2019年1月至2021年12月在天津市环湖医院住院的符合纳入标准的患者。对卒中组相关因素进行初步描述性统计,随后进行统计学分析。最后,采用受试者的受试者工作特征(receiver operating characteristic, ROC)曲线来判断显著因素对预后预测的敏感性和特异性。结果统计结果显示,脑损伤部位(λ2 = 7.550, P = 0.023)、脑疝(λ2 = 7.534, P = 0.006)、发病时格拉斯哥昏迷量表评分(t =−2.479,P = 0.017)是pDOC患者脑卒中后意识改善的有统计学意义的指标。ROC曲线显示,预测脑损伤部位(曲线下面积[AUC] = 0.766, 95%可信区间[CI]: 0.708 ~ 0.824)预后的敏感性和特异性分别为0.50和0.90,预测脑疝(AUC = 0.663, 95% CI: 0.594 ~ 0.732)预后的敏感性和特异性分别为0.73和0.60。GCS评分(AUC = 0.660, 95% CI: 0.596-0.724)预测预后的敏感性和特异性分别为0.35和0.92。结论男性脑卒中后pDOC的发生率高于女性,意识水平的改善率明显高于缺血性缺氧脑病。而脑卒中后pDOC患者意识水平的改善率与年龄、性别无关。发病时发生脑疝,脑卒中发生于脑干,发病时GCS评分低与意识水平预后差显著相关。
{"title":"Prognostic factors of prolonged disorder of consciousness after stroke: A single centre retrospective study","authors":"Yuzhang Wu,&nbsp;Zhongzhen Li,&nbsp;Keke Feng,&nbsp;Yifeng Cheng,&nbsp;Yangang Wang,&nbsp;Shaoya Yin","doi":"10.1016/j.jnrt.2022.100032","DOIUrl":"10.1016/j.jnrt.2022.100032","url":null,"abstract":"<div><h3>Background</h3><p>Stroke is a common disease in neurology, which often causes prolonged disorder of consciousness (pDOC) and brings a heavy burden to the patient's family and society. This study aims to explore the epidemiological factors of pDOC after stroke and the factors affecting the outcome of consciousness.</p></div><div><h3>Method</h3><p>The patients that admitted in Tianjin Huanhu Hospital from January 2019 to December 2021 and met the inclusion criteria were selected. Descriptive statistics was initially performed on the relevant factors of the stroke group, and statistical analysis was subsequently performed. Finally, to judge the sensitivity and specificity of the significant factors to the prediction of outcome, the receiver operating characteristic (ROC) curve of the participants was used.</p></div><div><h3>Result</h3><p>The statistical results showed that the location of brain injury (<em>λ</em><sup>2</sup> = 7.550, <em>P</em> = 0.023), cerebral hernia (<em>λ</em><sup>2</sup> = 7.534, <em>P</em> = 0.006), and Glasgow Coma Scale (GCS) score at onset (<em>t</em> = −2.479, <em>P</em> = 0.017) were statistically significant indicators in the improvement of consciousness in patients with pDOC after stroke. The ROC curve showed that the sensitivity and specificity of predicting the outcome of brain injury site (area under the curve [AUC] = 0.766, 95% confidence interval [CI]: 0.708–0.824) were 0.50 and 0.90, respectively, and that of cerebral hernia (AUC = 0.663, 95% CI: 0.594–0.732) were 0.73 and 0.60, respectively. The GCS score (AUC = 0.660, 95% CI: 0.596–0.724) predicted the outcome with sensitivity and specificity of 0.35 and 0.92, respectively.</p></div><div><h3>Conclusion</h3><p>The incidence rate of pDOC after stroke in men was higher than that in women, and the improvement rate in the consciousness level was significantly higher than that of ischemic–hypoxic encephalopathy. However, the improvement rate of the consciousness level in patients with pDOC after stroke was not related to age and gender. Cerebral hernia occurred at the time of onset, stroke occurred in the brainstem, and the low GCS score at the time of onset was significantly associated with the poor prognosis of consciousness level.</p></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"11 1","pages":"Article 100032"},"PeriodicalIF":3.3,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41474812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Magnetic resonance imaging-guided surgical strategies for treating trigeminal neuralgia without vascular compression 磁共振成像引导下治疗无血管压迫三叉神经痛的手术策略
IF 3.3 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-03-01 DOI: 10.1016/j.jnrt.2022.100029
Dezhong Liu, Saichao Yue, Kai Li, Yazhou Guo, Xiao Liu, Changwei Wang, Yu Liu, Bing He

Objective

To describe the surgical strategy, curative effect and postoperative complications of trigeminal neuralgia (TN) without vascular compression using head magnetic resonance imaging (MRI).

Methods

We retrospectively enrolled 184 patients with TN who were admitted to the Department of Neurosurgery of Zhoukou Central Hospital from January 2018 to March 2021 and had complete clinical data. Preoperative MRI reveled that 35 patients (19.0%) had no vascular compression. Among them, 16 (45.7%) had simple venous compression during surgery, 9 (25.7%) had venous compression and arachnoid adhesion during surgery, 5 (14.3%) had arachnoid adhesion during surgery, 3 (8.6%) had no venous compression or arachnoid adhesion during surgery, and 2 (5.7%) had simple artery compression during surgery. During the operation, the corresponding surgical strategies for the various types of venous compression were developed. Postoperative efficacy was assessed using the Barrow Neurological Institute pain intensity and facial numbness scores.

Results

According to the four types of compression identified during the operation, which did not reveal obvious vascular compression on preoperative head MRI, appropriate decompression methods were found to effectively relieve or eliminate pain (97.1%), and the postoperative effect was relatively satisfactory. There was no recurrence after 1–2 years of follow-up. After operation, two patients (5.7%) experienced occasional pain, one patient (2.9%) reported minor pain, and two patients (5.7%) reported numbness on the affected side of the face. Furthermore, one patient had aseptic meningitis (2.9%) and one patient (2.9%) had transient tinnitus or hearing loss on the affected side.

Conclusion

For patients with (TN) without vascular compression on head MRI prior to surgery, different surgical strategies can be implemented based on microvascular decompression and adequate trigeminal nerve decompression findings. Our results showed that these strategies could achieve satisfactory postoperative results without increasing postoperative complications.

目的应用头部磁共振成像(MRI)探讨无血管压迫的三叉神经痛(TN)的手术策略、疗效及术后并发症。方法对2018年1月至2021年3月入住周口市中心医院神经外科的184例TN患者进行回顾性分析。术前MRI显示35例(19.0%)患者无血管压迫。其中,16例(45.7%)在手术过程中有单纯静脉压迫,9例(25.7%)在术中有静脉压迫和蛛网膜粘连,5例(14.3%)在手术中有蛛网膜粘连、3例(8.6%)在术后没有静脉压迫或蛛网膜粘连和2例(5.7%)在外科手术中有单纯动脉压迫。在手术过程中,针对各种类型的静脉压迫制定了相应的手术策略。使用巴罗神经研究所疼痛强度和面部麻木评分评估术后疗效。结果根据术中发现的四种压迫类型,术前头部MRI未显示明显的血管压迫,发现合适的减压方法能有效缓解或消除疼痛(97.1%),术后效果相对满意。随访1-2年后无复发。术后,两名患者(5.7%)出现偶尔疼痛,一名患者(2.9%)报告轻微疼痛,两名病人(5.7%。此外,一名患者患有无菌性脑膜炎(2.9%),另一名患者(2.9%)患侧出现短暂耳鸣或听力损失。结论对于术前头部MRI未显示有血管压迫的(TN)患者,可根据微血管减压和三叉神经减压的适当发现采取不同的手术策略。我们的研究结果表明,这些策略可以在不增加术后并发症的情况下取得令人满意的术后效果。
{"title":"Magnetic resonance imaging-guided surgical strategies for treating trigeminal neuralgia without vascular compression","authors":"Dezhong Liu,&nbsp;Saichao Yue,&nbsp;Kai Li,&nbsp;Yazhou Guo,&nbsp;Xiao Liu,&nbsp;Changwei Wang,&nbsp;Yu Liu,&nbsp;Bing He","doi":"10.1016/j.jnrt.2022.100029","DOIUrl":"https://doi.org/10.1016/j.jnrt.2022.100029","url":null,"abstract":"<div><h3>Objective</h3><p>To describe the surgical strategy, curative effect and postoperative complications of trigeminal neuralgia (TN) without vascular compression using head magnetic resonance imaging (MRI).</p></div><div><h3>Methods</h3><p>We retrospectively enrolled 184 patients with TN who were admitted to the Department of Neurosurgery of Zhoukou Central Hospital from January 2018 to March 2021 and had complete clinical data. Preoperative MRI reveled that 35 patients (19.0%) had no vascular compression. Among them, 16 (45.7%) had simple venous compression during surgery, 9 (25.7%) had venous compression and arachnoid adhesion during surgery, 5 (14.3%) had arachnoid adhesion during surgery, 3 (8.6%) had no venous compression or arachnoid adhesion during surgery, and 2 (5.7%) had simple artery compression during surgery. During the operation, the corresponding surgical strategies for the various types of venous compression were developed. Postoperative efficacy was assessed using the Barrow Neurological Institute pain intensity and facial numbness scores.</p></div><div><h3>Results</h3><p>According to the four types of compression identified during the operation, which did not reveal obvious vascular compression on preoperative head MRI, appropriate decompression methods were found to effectively relieve or eliminate pain (97.1%), and the postoperative effect was relatively satisfactory. There was no recurrence after 1–2 years of follow-up. After operation, two patients (5.7%) experienced occasional pain, one patient (2.9%) reported minor pain, and two patients (5.7%) reported numbness on the affected side of the face. Furthermore, one patient had aseptic meningitis (2.9%) and one patient (2.9%) had transient tinnitus or hearing loss on the affected side.</p></div><div><h3>Conclusion</h3><p>For patients with (TN) without vascular compression on head MRI prior to surgery, different surgical strategies can be implemented based on microvascular decompression and adequate trigeminal nerve decompression findings. Our results showed that these strategies could achieve satisfactory postoperative results without increasing postoperative complications.</p></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"11 1","pages":"Article 100029"},"PeriodicalIF":3.3,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49888991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of tirofiban in patients with acute ischemic stroke without large-vessel occlusion and not receiving intravenous thrombolysis: A randomized controlled open-label trial 替罗非班在无大血管闭塞且未接受静脉溶栓治疗的急性缺血性卒中患者中的疗效和安全性:一项随机对照开放标签试验
IF 3.3 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2022-12-01 DOI: 10.1016/j.jnrt.2022.100026
Yongpeng Yu , Yali Zheng , Xia Dong , Xiaohong Qiao , Yu Tao

Objective

To investigate the effectiveness and safety of tirofiban in patients with acute ischemic stroke (AIS) without large-vessel occlusions and not receiving intravenous thrombolysis.

Methods

Overall, 267 cases were included in the study (134 cases in tirofiban group; 133 cases in control group). After admission, patients in the tirofiban group were administered tirofiban for at least 72 h, and aspirin 100 mg and hydroclopidogrel 75 mg were administered 4 h before discontinuation of tirofiban administration. All patients were followed for 3 months, and the National Institutes of Health Stroke Scale (NIHSS) scores on admission, 24 h, and 7 d after treatment, intracerebral hemorrhage transformation within 48 h from stroke onset, and bleeding were assessed.

Results

There was no significant difference between both groups in the incidence of non-symptomatic and symptomatic intracranial hemorrhage (sICH), extracranial hemorrhage events, and thrombocytopenia (p > 0.05). There was a significant different between the NIHSS scores at baseline and 7 d after treatment in the tirofiban group (p = 0.043). At 90 d after treatment, the proportion of patients with a good prognosis in the tirofiban group (modified Rankin Scale [mRS] = 0, 1) was higher than that in the control group (p = 0.021). There was no difference in the proportion of patients with a mRS score of 0–2 between the two groups (p > 0.05).

Conclusion

Administration of tirofiban for >72 h (72 h–108 h) is safe and can improve the long-term (90 d) prognosis of patients with AIS without large-vessel occlusions and not receiving intravenous thrombolysis.

目的探讨替罗非班治疗急性缺血性脑卒中(AIS)无大血管闭塞且未接受静脉溶栓治疗的有效性和安全性。方法共纳入267例患者(替罗非班组134例;对照组133例)。入院后,替罗非班组患者给予替罗非班治疗至少72小时,停药前4小时给予阿司匹林100 mg和氢氯吡格雷75 mg。随访3个月,评估入院时、治疗后24 h、7 d的美国国立卫生研究院卒中量表(NIHSS)评分、卒中发生后48 h内脑出血转化、出血情况。结果两组患者无症状性和症状性颅内出血(siich)、颅外出血事件和血小板减少(p >0.05)。替罗非班组NIHSS评分与治疗后7 d比较差异有统计学意义(p = 0.043)。治疗后90 d,替罗非班组(改良Rankin量表[mRS] = 0,1)预后良好的患者比例高于对照组(p = 0.021)。两组患者mRS评分为0-2分的比例差异无统计学意义(p >0.05)。结论替罗非班治疗72 h (72 h - 108 h)是安全的,可改善无大血管闭塞且未静脉溶栓的AIS患者的长期(90 d)预后。
{"title":"Efficacy and safety of tirofiban in patients with acute ischemic stroke without large-vessel occlusion and not receiving intravenous thrombolysis: A randomized controlled open-label trial","authors":"Yongpeng Yu ,&nbsp;Yali Zheng ,&nbsp;Xia Dong ,&nbsp;Xiaohong Qiao ,&nbsp;Yu Tao","doi":"10.1016/j.jnrt.2022.100026","DOIUrl":"10.1016/j.jnrt.2022.100026","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate the effectiveness and safety of tirofiban in patients with acute ischemic stroke (AIS) without large-vessel occlusions and not receiving intravenous thrombolysis.</p></div><div><h3>Methods</h3><p>Overall, 267 cases were included in the study (134 cases in tirofiban group; 133 cases in control group). After admission, patients in the tirofiban group were administered tirofiban for at least 72 h, and aspirin 100 mg and hydroclopidogrel 75 mg were administered 4 h before discontinuation of tirofiban administration. All patients were followed for 3 months, and the National Institutes of Health Stroke Scale (NIHSS) scores on admission, 24 h, and 7 d after treatment, intracerebral hemorrhage transformation within 48 h from stroke onset, and bleeding were assessed.</p></div><div><h3>Results</h3><p>There was no significant difference between both groups in the incidence of non-symptomatic and symptomatic intracranial hemorrhage (sICH), extracranial hemorrhage events, and thrombocytopenia (<em>p</em> &gt; 0.05). There was a significant different between the NIHSS scores at baseline and 7 d after treatment in the tirofiban group (<em>p</em> = 0.043). At 90 d after treatment, the proportion of patients with a good prognosis in the tirofiban group (modified Rankin Scale [mRS] = 0, 1) was higher than that in the control group (<em>p</em> = 0.021). There was no difference in the proportion of patients with a mRS score of 0–2 between the two groups (<em>p</em> &gt; 0.05).</p></div><div><h3>Conclusion</h3><p>Administration of tirofiban for &gt;72 h (72 h–108 h) is safe and can improve the long-term (90 d) prognosis of patients with AIS without large-vessel occlusions and not receiving intravenous thrombolysis.</p></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"10 4","pages":"Article 100026"},"PeriodicalIF":3.3,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2324242622001280/pdfft?md5=ad08c273c697b03ad27a1cd1da5e3b1b&pid=1-s2.0-S2324242622001280-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54660636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Atrophic cerebral peduncle may be a hallmark for evaluating the compensatory ability of the contralateral hemisphere 脑梗萎缩可能是评估对侧半球代偿能力的标志
IF 3.3 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2022-12-01 DOI: 10.1016/j.jnrt.2022.100024
Xiuyu Du

Hemorrhagic mirror stroke is a rare subtype of recurrent hemorrhagic stroke, similar to a cerebral hemorrhage in mirror position of the contralateral hemisphere. Here report two cases of hemorrhagic mirror stroke in the nondominant hemisphere of a right-handed man and a left-handed woman several years after the first similar onset in the dominant one. During rehabilitation after the first-time stroke, patients showed excellent recovery despite the development of atrophy in the cerebral peduncle on the affected side and aphasia and quadriplegia after the mirror stroke in the nondominant hemisphere. These cases not only highlight some uncommon clinical symptoms or the rare stroke type but also demonstrate the association between recovery of patients with atrophic cerebral peduncle after stroke and functional reorganization in the undamaged hemisphere.

出血性镜像中风是一种罕见的复发性出血性中风亚型,类似于对侧半球镜像位置的脑出血。本文报告两例出血性镜像中风,发生在一名右撇子男性和一名左撇子女性的非优势脑半球。在首次中风后的康复过程中,患者表现出良好的恢复,尽管患侧脑梗出现萎缩,非优势半球镜像中风后出现失语和四肢瘫痪。这些病例不仅突出了一些罕见的临床症状或罕见的脑卒中类型,而且表明脑梗萎缩患者脑卒中后的恢复与未受损半球的功能重组之间存在关联。
{"title":"Atrophic cerebral peduncle may be a hallmark for evaluating the compensatory ability of the contralateral hemisphere","authors":"Xiuyu Du","doi":"10.1016/j.jnrt.2022.100024","DOIUrl":"10.1016/j.jnrt.2022.100024","url":null,"abstract":"<div><p>Hemorrhagic mirror stroke is a rare subtype of recurrent hemorrhagic stroke, similar to a cerebral hemorrhage in mirror position of the contralateral hemisphere. Here report two cases of hemorrhagic mirror stroke in the nondominant hemisphere of a right-handed man and a left-handed woman several years after the first similar onset in the dominant one. During rehabilitation after the first-time stroke, patients showed excellent recovery despite the development of atrophy in the cerebral peduncle on the affected side and aphasia and quadriplegia after the mirror stroke in the nondominant hemisphere. These cases not only highlight some uncommon clinical symptoms or the rare stroke type but also demonstrate the association between recovery of patients with atrophic cerebral peduncle after stroke and functional reorganization in the undamaged hemisphere.</p></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"10 4","pages":"Article 100024"},"PeriodicalIF":3.3,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2324242622001267/pdfft?md5=173465b9b1feef7d0cf1467ea0bf75af&pid=1-s2.0-S2324242622001267-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47546872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alliance for polio survivors, needed or not? Meeting summary of Symposium on Population Medicine & Management of Poliomyelitis Survivors (2021, Beijing) 脊髓灰质炎幸存者联盟,是否需要?2021年北京脊髓灰质炎幸存者人口医学与管理学术研讨会会议纪要
IF 3.3 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2022-12-01 DOI: 10.1016/j.jnrt.2022.100025
Jiancheng Zang, Zengyu Wu, Xiaomei Zhai
{"title":"Alliance for polio survivors, needed or not? Meeting summary of Symposium on Population Medicine & Management of Poliomyelitis Survivors (2021, Beijing)","authors":"Jiancheng Zang,&nbsp;Zengyu Wu,&nbsp;Xiaomei Zhai","doi":"10.1016/j.jnrt.2022.100025","DOIUrl":"10.1016/j.jnrt.2022.100025","url":null,"abstract":"","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"10 4","pages":"Article 100025"},"PeriodicalIF":3.3,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2324242622001279/pdfft?md5=69d609d801a968e87b45c1dda395295b&pid=1-s2.0-S2324242622001279-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46866106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The role of maternal immune activation in the immunological and neurological pathogenesis of autism 母体免疫激活在自闭症的免疫和神经发病机制中的作用
IF 3.3 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2022-11-01 DOI: 10.1016/j.jnrt.2022.100030
Keqin Liu, Yi Huang, Yufei Zhu, Yan Zhao, Xiangyin Kong
{"title":"The role of maternal immune activation in the immunological and neurological pathogenesis of autism","authors":"Keqin Liu, Yi Huang, Yufei Zhu, Yan Zhao, Xiangyin Kong","doi":"10.1016/j.jnrt.2022.100030","DOIUrl":"https://doi.org/10.1016/j.jnrt.2022.100030","url":null,"abstract":"","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45094366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of Neurorestoratology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1